Yeomans Consulting Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,830
Closed -$227K 95
2024
Q2
$227K Sell
1,830
-138
-7% -$17.8K 0.09% 83
2024
Q1
$260K Sell
1,968
-91
-4% -$11.2K 0.11% 66
2023
Q4
$224K Buy
+2,059
New +$214K 0.11% 63

Other funds holding MRK

Yeomans Consulting Group's MRK Position: Q3 2024 in Review

Yeomans Consulting Group sold out of Merck (MRK) in Q3 2024, closing a stake of 1,830 shares — an estimated $227K sold.

Yeomans Consulting Group first reported a position in MRK in Q4 2023 and held it in 3 quarters. The position peaked at $260K in Q1 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Yeomans Consulting Group reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Yeomans Consulting Group sold 1,830 Merck shares in Q3 2024, an estimated $227K.
  • Yeomans Consulting Group first reported a position in Merck in Q4 2023 and held it in 3 quarters.
  • Yeomans Consulting Group's Merck position peaked at $260K in Q1 2024.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Yeomans Consulting Group's 13F filing for Q3 2024, filed 24 Oct 2024.